MANCHESTER MANAGEMENT COMPANY, LLC 13D and 13G filings for NeuroOne Medical Technologies Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 3:11 pm Sale | 2024-12-31 | 13G | NeuroOne Medical Technologies Corporation NMTC | MANCHESTER MANAGEMENT COMPANY, LLC | 1,583,332 4.900% | -854,794 (-35.06%) | Filing |
| 2023-08-01 7:04 pm Purchase | 2023-07-27 | 13G | NeuroOne Medical Technologies Corporation NMTC | MANCHESTER MANAGEMENT COMPANY, LLC | 2,438,126 9.999% | 2,438,126 (New Position) | Filing |